BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26359454)

  • 1. Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS.
    Zhang X; Yu X; Jiang G; Miao Y; Wang L; Zhang Y; Liu Y; Fan C; Lin X; Dong Q; Han Q; Zhao H; Han Y; Han X; Rong X; Ding S; Wang E; Wang E
    Cancer Res; 2015 Nov; 75(21):4527-37. PubMed ID: 26359454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic TMEM88 promotes triple-negative breast cancer by interacting with Dvl.
    Yu X; Zhang X; Zhang Y; Jiang G; Mao X; Jin F
    Oncotarget; 2015 Sep; 6(28):25034-45. PubMed ID: 26325443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.
    Zhang X; Zhou H; Zhang Y; Cai L; Jiang G; Li A; Miao Y; Li Q; Qiu X; Wang E
    Oncotarget; 2017 Jun; 8(24):38863-38875. PubMed ID: 28418919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling pathway in non-small cell lung cancer.
    Stewart DJ
    J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis.
    Han Q; Lin X; Zhang X; Jiang G; Zhang Y; Miao Y; Rong X; Zheng X; Han Y; Han X; Wu J; Kremerskothen J; Wang E
    J Pathol; 2017 Aug; 242(4):435-447. PubMed ID: 28543074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta.
    Bikkavilli RK; Feigin ME; Malbon CC
    J Cell Sci; 2008 Nov; 121(Pt 21):3598-607. PubMed ID: 18946023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
    Zhang S; Wang Y; Dai SD; Wang EH
    BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
    Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
    Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling.
    He W; He S; Wang Z; Shen H; Fang W; Zhang Y; Qian W; Lin M; Yuan J; Wang J; Huang W; Wang L; Ke Z
    BMC Cancer; 2015 Mar; 15():107. PubMed ID: 25880337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitogen-activated protein kinase kinase kinase kinase GCKR positively regulates canonical and noncanonical Wnt signaling in B lymphocytes.
    Shi CS; Huang NN; Harrison K; Han SB; Kehrl JH
    Mol Cell Biol; 2006 Sep; 26(17):6511-21. PubMed ID: 16914735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression.
    Wei Q; Zhao Y; Yang ZQ; Dong QZ; Dong XJ; Han Y; Zhao C; Wang EH
    Lung Cancer; 2008 Nov; 62(2):181-92. PubMed ID: 18692936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
    Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
    Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of transmembrane protein 88 (TMEM88) as a dishevelled-binding protein.
    Lee HJ; Finkelstein D; Li X; Wu D; Shi DL; Zheng JJ
    J Biol Chem; 2010 Dec; 285(53):41549-56. PubMed ID: 21044957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway.
    Ge YX; Wang CH; Hu FY; Pan LX; Min J; Niu KY; Zhang L; Li J; Xu T
    J Cell Physiol; 2018 Jan; 233(1):79-87. PubMed ID: 28181235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
    Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
    Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
    Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
    Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMEM88 mediates inflammatory cytokines secretion by regulating JNK/P38 and canonical Wnt/β-catenin signaling pathway in LX-2 cells.
    Xu T; Pan LX; Ge YX; Li P; Meng XM; Huang C; Li J
    Inflammopharmacology; 2018 Oct; 26(5):1339-1348. PubMed ID: 29159713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
    Zhang X; Cai L; Zhou H; Liu Y; Fan C; Wang L; Li A; Miao Y; Li Q; Qiu X; Wang E
    Mol Carcinog; 2017 Dec; 56(12):2558-2565. PubMed ID: 28667800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.